Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic castration-resistant prostate cancer (Q33399759)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic castration-resistant prostate cancer |
scientific article |
Statements
1 reference
Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic castration-resistant prostate cancer (English)
1 reference
Tomasz M Beer
1 reference
Mark T Fleming
1 reference
Guru Sonpavde
1 reference
Michael Kolodziej
1 reference
Sanjay Awasthi
1 reference
Thomas E Hutson
1 reference
Danko Martincic
1 reference
Ashutosh Rastogi
1 reference
Steven R Rousey
1 reference
Ralph E Weinstein
1 reference
Matthew D Galsky
1 reference
William R Berry
1 reference
Yunfei Wang
1 reference
Kristi A Boehm
1 reference
Lina Asmar
1 reference
Mary A Rauch
1 reference
1 March 2012
1 reference
1 reference
10
1 reference
6-14
1 reference
Identifiers
1 reference
1 reference